Zeck Huang
Sr. Director Nonclinical Lead,
WuXi Biologics
Zeck had 25+ years of experience in non-clinical studies (PD, PK, Tox) in big pharma (Pfizer, GSK) and biotech (Cephalon, Junshi, Otsuka, Juventas, Vaccitech), has involved in many lead ID/optimization projects. He also had 6+ years global regulatory submission (FDA, EMA, CDE, etc), including 25+ IND and 5+ BLA/NDA. He has working experience with novel biologics, including mAb, bsAb, ADC, vaccine, cell therapy product (CAR- T) and gene therapy products (AAV, oncolytic virus, etc).
Zeck received his M.D from Medical School of Fudan University (formerly Shanghai Medical University) in China, and his Ph.D. in Toxicology from the University at Albany SUNY, USA.
Zeck received his M.D from Medical School of Fudan University (formerly Shanghai Medical University) in China, and his Ph.D. in Toxicology from the University at Albany SUNY, USA.